Showing 1 - 9 results of 9 for search 'Federica Bono', query time: 0.02s Refine Results
  1. 1
    Dopamine D3 Receptor Heteromerization: Implications for Neuroplasticity and Neuroprotection

    Dopamine D3 Receptor Heteromerization: Implications for Neuroplasticity and Neuroprotection by Federica Bono, Veronica Mutti, Chiara Fiorentini, Cristina Missale

    Published 2020-07-01
    Get full text
    Article
  2. 2
    Editorial: Advances in brain disorders: from mechanisms to therapeutic targets

    Editorial: Advances in brain disorders: from mechanisms to therapeutic targets by Federica Bono, Giulia Abate, Sara Anna Bonini, Maria Josè Sisalli, Arianna Bellucci

    Published 2023-11-01
    Get full text
    Article
  3. 3
    G Protein-Dependent Activation of the PKA-Erk1/2 Pathway by the Striatal Dopamine D1/D3 Receptor Heteromer Involves Beta-Arrestin and the Tyrosine Phosphatase Shp-2

    G Protein-Dependent Activation of the PKA-Erk1/2 Pathway by the Striatal Dopamine D1/D3 Receptor Heteromer Involves Beta-Arrestin and the Tyrosine Phosphatase Shp-2 by Federica Bono, Zaira Tomasoni, Veronica Mutti, Giulia Sbrini, Rajesh Kumar, Francesca Longhena, Chiara Fiorentini, Cristina Missale

    Published 2023-03-01
    Get full text
    Article
  4. 4
    Central nervous system interaction and crosstalk between nAChRs and other ionotropic and metabotropic neurotransmitter receptors

    Central nervous system interaction and crosstalk between nAChRs and other ionotropic and metabotropic neurotransmitter receptors by Federica Bono, Chiara Fiorentini, Veronica Mutti, Zaira Tomasoni, Giulia Sbrini, Hanna Trebesova, Mario Marchi, Massimo Grilli, Cristina Missale

    Published 2023-04-01
    Get full text
    Article
  5. 5
    Generation of human induced pluripotent stem cell lines derived from three Noonan syndrome patients from a single family carrying the heterozygous PTPN11 c.188 A > G (p.Y63C) mutation

    Generation of human induced pluripotent stem cell lines derived from three Noonan syndrome patients from a single family carrying the heterozygous PTPN11 c.188 A > G (p.Y63C) mutat... by Giulia Sbrini, Zaira Tomasoni, Maria Rosa Cutrì, Alba Pilotta, Chiara Mingotti, Raffaele Badolato, Luca La Via, Alessandro Barbon, Federica Bono, Chiara Fiorentini

    Published 2024-02-01
    Get full text
    Article
  6. 6
    Ropinirole and Pramipexole Promote Structural Plasticity in Human iPSC-Derived Dopaminergic Neurons via BDNF and mTOR Signaling

    Ropinirole and Pramipexole Promote Structural Plasticity in Human iPSC-Derived Dopaminergic Neurons via BDNF and mTOR Signaling by Ginetta Collo, Laura Cavalleri, Federica Bono, Cristina Mora, Stefania Fedele, Roberto William Invernizzi, Massimo Gennarelli, Giovanna Piovani, Tilo Kunath, Mark J. Millan, Emilio Merlo Pich, PierFranco Spano

    Published 2018-01-01
    Get full text
    Article
  7. 7
    NOVEL COMPOUNDS TARGETING SYNAPSIN III RESCUE ALPHA-SYNUCLEIN AGGREGATION AND NIGROSTRIATAL DYSFUNCTION AND DEGENERATION IN EXPERIMENTAL MODELS OF PARKINSON’S DISEASE

    NOVEL COMPOUNDS TARGETING SYNAPSIN III RESCUE ALPHA-SYNUCLEIN AGGREGATION AND NIGROSTRIATAL DYSFUNCTION AND DEGENERATION IN EXPERIMENTAL MODELS OF PARKINSON’S DISEASE by Francesca Longhena, Gaia Faustini, Andrea Casiraghi, Valentina Straniero, Giovanni Ribaudo, Veronica Mutti, Gisela Camacho-Hernandez, Cristina Missale, Amy Hauck Newman, Federica Bono, Alessandra Gianoncelli, Ermanno Valoti, Arianna Bellucci

    Published 2023-10-01
    Get full text
    Article
  8. 8
    Synapsin III Regulates Dopaminergic Neuron Development in Vertebrates

    Synapsin III Regulates Dopaminergic Neuron Development in Vertebrates by Gaia Faustini, Francesca Longhena, Alessia Muscò, Federica Bono, Edoardo Parrella, Luca La Via, Alessandro Barbon, Marina Pizzi, Franco Onofri, Fabio Benfenati, Cristina Missale, Maurizio Memo, Daniela Zizioli, Arianna Bellucci

    Published 2022-12-01
    Get full text
    Article
  9. 9
    Methylphenidate Analogues as a New Class of Potential Disease-Modifying Agents for Parkinson’s Disease: Evidence from Cell Models and Alpha-Synuclein Transgenic Mice

    Methylphenidate Analogues as a New Class of Potential Disease-Modifying Agents for Parkinson’s Disease: Evidence from Cell Models and Alpha-Synuclein Transgenic Mice by Andrea Casiraghi, Francesca Longhena, Gaia Faustini, Giovanni Ribaudo, Lorenzo Suigo, Gisela Andrea Camacho-Hernandez, Federica Bono, Viviana Brembati, Amy Hauck Newman, Alessandra Gianoncelli, Valentina Straniero, Arianna Bellucci, Ermanno Valoti

    Published 2022-07-01
    Get full text
    Article

Search Tools: